Stack Lab
Compare compound mechanisms, evidence quality, related research topics, receptor considerations, and live COA-verified prices. Add 1–5 compounds.
Research signals
- Dual Incretin AgonistRich researchBreakout
- TesamorelinRich researchRising
- Triple AgonistRich researchBreakout
- KPVRich researchRising
- 5-Amino-1MQRich researchBreakout
Receptor Compatibility
Redundancy, true conflicts, and dangerous additive effects
Receptor conflicts not yet analyzed for this stack
Evidence review
A structured review of the evidence for this stack
Sign in to build a structured evidence review for Dual Incretin Agonist + Tesamorelin + Triple Agonist + KPV + 5-Amino-1MQ — mechanisms, evidence, endpoints, and limitations grounded in documented research.
Community data
Aggregate research activity for this selection
1 researcher has logged this combination on VialTalk
Early signal — this combination is newly tracked. The picture sharpens as more researchers log it.
Pricing snapshot
Best price for each compound today
- 4 panels$17.10 · 10mg$1.71/mg
- 8 panels$27.90 · 10mg$2.79/mg
- 8 panels$21 · 10mg$2.10/mg
- 3 panels$21 · 10mg$2.10/mg
- 3 panels$26.99 · 50mg$0.54/mg
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.